“Take a few extra minutes to go beyond your reporter’s spiel to explain how you put a story together, and what your source can expect.” Every day, for four decades, I have put my right shoe on first, ...

Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...

SAN FRANCISCO, CA AND NEWTON, MA, July 9, 2026 (Newswire.com) - Unlearn, a pioneer of AI-powered solutions for clinical development, today announced a collaboration with Acumen Pharmaceuticals (Acumen ...

The idea of digital twins -- digital representations of humans built with computer models -- for medical research is gaining traction in private and academic sectors. With predictive simulation ...

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

SAN FRANCISCO--(BUSINESS WIRE)--After securing over $130M in funding and achieving multiple regulatory successes, Unlearn today announced changes to its executive leadership to support the commercial ...

Reflecting on the importance and art of reskilling — learning and unlearning — comes at a timely moment. The Covid-19 pandemic has permitted us to learn how important soft skills are, and, more ...

SAN FRANCISCO, CA / ACCESS Newswire / February 12, 2026 / Unlearn, a leader in AI solutions for clinical trials, today announced it is partnering with VectorY Therapeutics, a biotechnology company ...

While it is true that experiences are an indispensable part of learning to start a venture, we must not forget that focusing an idea on innovation and not on established paradigms can be much more ...

Twins have long played a role in the world of medical research, specifically in the area of clinical trials, where they can help measure the effectiveness of a therapy by applying a control to one of ...